5 Stocks To Watch For September 28, 2021
Some of the stocks that may grab investor focus today are:
Wall Street expects FactSet Research Systems Inc. (NYSE: FDS) to report quarterly earnings at $2.72 per share on revenue of $404.97 million after the closing bell. FactSet Research shares dropped 1% to close at $369.12 on Monday.
Why Acceleron Pharma Stock Is Trading Higher Today
Acceleron Pharma (NASDAQ: XLRN) shares are trading higher after Bloomberg reported the company is in talks for a potential $11 billion buyout.
CFO & Treasurer Of Acceleron Pharma Trades $5.01 Million In Company Stock
Kevin F Mclaughlin, CFO & Treasurer at Acceleron Pharma (NASDAQ:XLRN), made a large buy and sell of company shares on September 24, according to a new SEC filing.
10 Biggest Price Target Changes For Monday
Morgan Stanley cut Amazon.com, Inc. (NASDAQ: AMZN) price target from $4,300 to $4,100. Amazon shares fell 0.6% to $3,406.00 in pre-market trading.
RBC Capital Maintains Sector Perform on Acceleron Pharma, Raises Price Target to $179
RBC Capital analyst Kennen MacKay maintains Acceleron Pharma (NASDAQ:XLRN) with a Sector Perform and raises the price target from $113 to $179.
Acceleron In Advanced $11B Buyout Talks: Bloomberg
Frothy rumors about possible M&A discussions at Acceleron Pharma Inc (NASDAQ:XLRN) were capped with a Bloomberg report asserting that the Company is…
SVP And General Counsel Sec. Of Acceleron Pharma Trades $1.21 Million In Company Stock
Adam M Veness, SVP And General Counsel Sec. at Acceleron Pharma (NASDAQ:XLRN), made a large buy and sell of company shares on September 21, according to a new SEC filing.
The Daily Biotech Pulse: Restricted Authorization For Pfizer’s COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 22)